Chorioamnionitis: Causes, Diagnosis, and Fetal Risks

Chorioamnionitis is an inflammation of the membranes surrounding the fetus, most often triggered by bacteria that climb upward from the vagina into the uterus during pregnancy. It complicates roughly one to four percent of all deliveries, though the rate is much higher in very preterm births. The condition matters because it threatens both the pregnant person and the baby, raising the odds of preterm delivery, neonatal infection, and a cascade of complications that can extend well beyond the delivery room.

How Bacteria Reach the Fetal Membranes

The most common route is ascending infection. Microorganisms that normally live in the vagina or cervix migrate upward through the cervical canal, reach the space between the membranes, and eventually invade the amniotic fluid. This can happen before labor starts, during labor, or after the membranes rupture. Less frequently, bacteria arrive through the bloodstream or are introduced during invasive procedures like amniocentesis, but the ascending pathway accounts for the vast majority of cases.

The identity of the culprit bacteria has shifted with better detection methods. Ureaplasma species, tiny organisms that often colonize the genital tract without causing symptoms, are the microorganisms most frequently isolated from amniotic fluid and placentas of people who deliver preterm.¹ One study using advanced molecular techniques found that Ureaplasma was the dominant organism in acute chorioamnionitis cases, including five infections that standard cultures missed entirely.² Ureaplasma parvum, in particular, carried about a fivefold increased odds of chorioamnionitis in cases of extreme preterm labor and was more common in second-trimester deliveries than in third-trimester ones.³ Other organisms, including Group B Streptococcus, Gardnerella vaginalis, Escherichia coli, and Staphylococcus aureus, also play roles, but Ureaplasma’s dominance helps explain why many cases go undetected by routine culture.

Clinical Versus Histological Diagnosis

One reason chorioamnionitis can be confusing is that the term refers to two overlapping but distinct conditions. Clinical chorioamnionitis is diagnosed at the bedside, typically when a laboring person develops a fever along with other signs such as a rapid heart rate, uterine tenderness, or foul-smelling amniotic fluid. Histological chorioamnionitis, by contrast, is discovered only after delivery, when a pathologist examines the placenta under a microscope and finds inflammatory cells infiltrating the membranes.

These two diagnoses do not always overlap. In one large study, 335 cases had histological chorioamnionitis alone with no clinical signs during labor, while only 20 cases showed both clinical and histological disease.⁴ That means the majority of membrane inflammation is “silent,” producing no fever or symptoms the clinical team would notice. This matters because histological chorioamnionitis can still affect the baby even when the mother felt fine during delivery.

Recognizing the limitations of the catch-all label, a panel convened by the National Institute of Child Health and Human Development proposed replacing “chorioamnionitis” with a more specific framework called “Triple I,” standing for intrauterine inflammation, infection, or both. The panel emphasized that isolated maternal fever should not automatically lead to a diagnosis of infection or trigger antibiotic therapy, since fever during labor can have other causes.⁵ In practice, many clinicians still use “chorioamnionitis” loosely, but the Triple I framework is gradually changing how the condition is classified and managed.

Inflammation Without Infection

Not all intrauterine inflammation involves bacteria. Sterile intra-amniotic inflammation, where the immune system revs up without a detectable microorganism, is a recognized phenomenon in preterm labor. Research using RNA sequencing on fetal membranes has shown that the immune response in sterile inflammation is milder than what bacteria provoke, involving alarm signals from the body’s own damaged cells rather than microbial invaders.⁶

One marker that helps distinguish these cases is a molecule called HMGB1, released by stressed or dying cells. In people with preterm labor and sterile inflammation, higher concentrations of HMGB1 in amniotic fluid predicted delivery within a week, with those above a certain threshold being about five times more likely to deliver that quickly.⁷ The distinction between sterile and microbial inflammation matters for treatment: antibiotics can address infection-driven cases, but sterile inflammation might respond better to anti-inflammatory medications such as corticosteroids or drugs that target the body’s own inflammatory machinery.⁸

What Raises the Risk

Several factors during labor and pregnancy influence whether chorioamnionitis develops. A large international study of term pregnancies with prelabor rupture of membranes identified repeated vaginal examinations as one of the strongest predictors. More than eight digital exams carried roughly a fivefold increase in the odds of clinical chorioamnionitis compared to two or fewer exams. Prolonged active labor, especially beyond twelve hours, increased the odds about fourfold. Other contributors included meconium-stained amniotic fluid, being pregnant for the first time, longer intervals between membrane rupture and active labor, and Group B Streptococcus colonization.⁹

A more recent analysis confirmed the cervical-exam finding in a contemporary population, showing that eight or more exams nearly doubled the risk of developing clinical chorioamnionitis after accounting for other variables. That study also flagged prolonged membrane rupture, first-time pregnancy, higher body mass index, and higher gestational age as independent risk factors.¹⁰ The practical takeaway is that minimizing unnecessary vaginal exams during labor, especially after membranes have ruptured, is one modifiable step that clinical teams can take.

The Vaginal Microbiome Connection

The composition of vaginal bacteria before and during pregnancy appears to set the stage for infection risk. In pregnancies that eventually resulted in preterm membrane rupture, vaginal dysbiosis characterized by the loss of protective Lactobacillus bacteria was present in roughly a third of cases before the membranes even broke, compared to none of the term-delivery controls.¹¹ Depletion of Lactobacillus and increased abundance of organisms like Sneathia were linked to subsequent funisitis (inflammation of the umbilical cord) and early-onset neonatal sepsis.

Counterintuitively, erythromycin treatment, one of the standard antibiotics given after preterm premature rupture of membranes, appeared to worsen the dysbiosis, especially in people who had started out with healthy Lactobacillus colonization.¹² This creates a tension in clinical practice: the antibiotics clearly delay delivery and reduce certain infections, but they may simultaneously strip away protective bacteria. It is an area where the evidence is evolving, and future approaches might involve pairing antibiotics with strategies to preserve or restore beneficial vaginal microbes.

Consequences for the Baby

The fetal response to intrauterine inflammation can be intense. When infection reaches the amniotic fluid, chemical signals attract immune cells that migrate into the umbilical cord, a process called funisitis. This cord inflammation is the hallmark of what researchers call the fetal inflammatory response syndrome, defined by elevated levels of the cytokine interleukin-6 in fetal blood.¹³ The more advanced the inflammation in the umbilical cord, the higher the odds of suspected early-onset neonatal sepsis and chorioamnionitis itself, with the most severe stage carrying roughly an elevenfold increase in sepsis risk after adjusting for gestational age.¹⁴

At the molecular level, fetal inflammatory response syndrome driven by infection involves a surge in innate immune activity, with neutrophils and monocytes ramping up while T cell functions are suppressed.¹⁵ This imbalance helps explain some of the downstream problems: the inflammatory cascade does not stay contained in the membranes but can reach the fetal brain and lungs.

Brain and Neurological Risks

A meta-analysis found that clinical chorioamnionitis was associated with roughly a twofold increase in the risk of cerebral palsy in preterm infants and a threefold increase in cystic periventricular leukomalacia, a type of white-matter brain injury.¹⁶ Histological chorioamnionitis showed a similar but slightly weaker link. More severe placental inflammation, graded by pathologists into stages, further stratifies risk: moderate-to-severe maternal and fetal inflammatory responses were each independently associated with cognitive impairment and cerebral palsy even after accounting for gestational age and birth weight.¹⁷

Lung Development

The relationship between chorioamnionitis and bronchopulmonary dysplasia, the chronic lung disease of prematurity, is more complicated than it first appears. A large meta-analysis pooling over 100 studies found a statistically significant association between chorioamnionitis and bronchopulmonary dysplasia, with about a 30 percent increase in odds when the disease was defined at 36 weeks postmenstrual age.¹⁸ However, a cohort study that carefully separated infants by the reason for their preterm birth found that histological chorioamnionitis was not associated with bronchopulmonary dysplasia once you looked only at babies born after preterm labor or preterm membrane rupture. The apparent overall link was driven largely by a subgroup of growth-restricted infants who had high rates of bronchopulmonary dysplasia but low rates of chorioamnionitis, which skewed the comparison.¹⁹ So while exposure to intrauterine inflammation clearly matters for lung health, the size of the effect depends heavily on context and which babies are being compared.

Consequences for the Mother

Chorioamnionitis does not just endanger the baby. In a population-level analysis of more than 1.3 million live births in Ohio over a decade, about 1.3 percent were complicated by chorioamnionitis. Even after adjusting for other risks, affected individuals had a two- to threefold increased risk of a composite of adverse outcomes including intensive care admission, blood transfusion, uterine rupture, and unplanned surgery after delivery.

One specific mechanism behind maternal complications involves uterine contractility. Chorioamnionitis is associated with weakened contractions of the uterine muscle, and this decline seems to begin about two hours after the onset of maternal fever. The uterus also becomes less responsive to oxytocin, the drug used to augment labor. The result is an increased rate of cesarean delivery and a clinically significant rate of postpartum hemorrhage, reported at about 32 percent in one study of suspected chorioamnionitis cases.²⁰ For clinical teams, this means that the longer the interval between infection and delivery, the greater the likelihood that contractions will falter, though current evidence suggests that the timing between diagnosis and delivery does not change most other outcomes.

Treatment During Labor

Once clinical chorioamnionitis is diagnosed, the standard response has two prongs: start antibiotics and plan for delivery. The first-line regimen is intravenous ampicillin combined with gentamicin, given during labor. If a cesarean delivery becomes necessary, clindamycin is added at the time of cord clamping to broaden coverage against anaerobic bacteria. Vaginal delivery remains the preferred route; cesarean is reserved for the usual obstetric reasons and is not done simply because of the infection.²¹

Whether alternative antibiotic combinations work as well is an active area of study. A retrospective comparison of ceftriaxone-metronidazole versus ampicillin-tobramycin found similar maternal outcomes between the two regimens, but the ampicillin-based combination was associated with a lower rate of early-onset neonatal sepsis, roughly 3 percent compared to about 11 percent with ceftriaxone-metronidazole.²² That finding, while from a single retrospective study, supports ampicillin-based regimens as the default and suggests caution before switching to broader-spectrum alternatives without clear justification.

Prevention When Membranes Rupture Early

Preterm premature rupture of membranes, where the water breaks before 37 weeks without labor starting, is one of the most common precursors to chorioamnionitis. In these situations, the strategy is expectant management, meaning clinicians try to buy time for the baby to mature while monitoring closely for signs of infection. A Cochrane review found that prophylactic antibiotics following preterm membrane rupture significantly delayed delivery and reduced markers of neonatal illness, supporting their routine use. The review also flagged that co-amoxiclav (amoxicillin-clavulanate) was associated with an increased rate of necrotizing enterocolitis in newborns and should be avoided. Erythromycin emerged as the preferred antibiotic.²³

The recommended regimen for expectant management is typically a seven-day course starting with intravenous ampicillin and erythromycin, then transitioning to oral amoxicillin and erythromycin, given to those with preterm premature rupture of membranes before 34 weeks.²⁴ A network meta-analysis comparing different latency antibiotic approaches found that penicillins were the only class with clearly superior effectiveness against maternal chorioamnionitis. Interestingly, clindamycin alone actually increased the risk of maternal infection, reinforcing that not all antibiotics are interchangeable in this setting.²⁵

Emerging Diagnostic Tools

Diagnosing intra-amniotic inflammation traditionally requires amniocentesis, an invasive procedure that is not practical in every clinical situation. Researchers have been working on faster and less invasive alternatives. Point-of-care rapid tests for two markers, interleukin-6 and the enzyme MMP-8, can be run on amniotic fluid and produce results much faster than standard lab assays. Both tests achieved about 86 percent sensitivity for detecting intra-amniotic inflammation in people with preterm labor and intact membranes, though the MMP-8 test showed slightly better specificity.²⁶

Even more promising is the prospect of skipping amniocentesis altogether. Testing interleukin-6 levels in vaginal fluid, rather than amniotic fluid, has shown good specificity and negative predictive value for identifying intra-amniotic inflammation in people with preterm premature rupture of membranes.²⁷ A high negative predictive value means that if the test comes back low, you can be reasonably confident that dangerous inflammation is not happening inside the uterus. This kind of noninvasive screening could help clinicians decide who needs aggressive treatment and who can safely continue expectant management.

The Role of the Cervix as a Physical Barrier

Because most infections ascend from the vagina, the cervix acts as a gatekeeper. When it shortens prematurely or dilates early, that barrier weakens. In a mouse model, researchers found that surgically placing a cerclage (a suture that holds the cervix closed) completely prevented bacteria from ascending into the uterus within 24 hours. In control mice without the cerclage, bioluminescent bacteria had spread into the uterine horns, placenta, and fetal membranes. The cerclage also significantly reduced inflammatory gene expression in those tissues.²⁸ While mouse physiology is not identical to human, this work supports the idea that maintaining cervical integrity plays a direct role in blocking the ascending infection pathway. In human obstetrics, cerclage is already used for people with cervical insufficiency, and these findings provide a biological rationale for why it might also help reduce infection risk, not just mechanical preterm birth.

Placental Grading and Long-Term Prognosis

Not all histological chorioamnionitis carries the same weight. Pathologists grade the severity using a staging system that reflects how deeply inflammatory cells have penetrated and whether the fetal side is involved. In very preterm infants, those with moderate-to-severe inflammation on the maternal side of the membranes had higher rates of severe intraventricular hemorrhage, early-onset sepsis, and bronchopulmonary dysplasia compared to those with mild inflammation. Crucially, advanced-stage maternal and fetal inflammatory responses were independently associated with cognitive impairment and cerebral palsy on long-term follow-up, even after adjusting for confounders like gestational age and birth weight.²⁹ This means the pathology report from the placenta is not just an academic exercise. For neonatologists following a very preterm infant, the grade of inflammation helps calibrate expectations and guide the intensity of developmental surveillance in the months and years after discharge.